Gainesville, FL, United States of America

Chaoyong Yang


Average Co-Inventor Count = 2.4

ph-index = 1


Location History:

  • El Cerrito, CA (US) (2012)
  • Gainesville, FL (US) (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chaoyong Yang: Innovator in Molecular Probes and Nanoparticles

Introduction

Chaoyong Yang is a prominent inventor based in Gainesville, FL (US). He has made significant contributions to the field of molecular probes and nanoparticles, holding a total of 2 patents. His work focuses on advancing bioanalytical techniques through innovative technologies.

Latest Patents

Yang's latest patents include "Multi-acceptor molecular probes and applications thereof" and "Multiple component nanoparticles for multiplexed signaling and optical encoding." The first patent describes an oligonucleotide-based molecular probe that features a pin loop with a loop sequence complementary to a target sequence. This probe includes a first stem sequence with a fluorescent label and a second stem sequence with multiple quencher molecules. The second patent presents multiple-luminophore silica nanoparticles designed for multiplexed signaling in bioanalysis. These nanoparticles can simultaneously entrap various luminophores, enabling rapid and high-throughput multiplexed detection.

Career Highlights

Chaoyong Yang is affiliated with the University of Florida Research Foundation, Incorporated. His work has significantly impacted the development of advanced molecular probes and nanoparticles, enhancing the capabilities of bioanalytical methods.

Collaborations

Yang has collaborated with notable colleagues, including Weihong Tan and Lin Wang, contributing to the advancement of research in his field.

Conclusion

Chaoyong Yang's innovative work in molecular probes and nanoparticles exemplifies the importance of research in enhancing bioanalytical techniques. His contributions continue to influence the scientific community and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…